Published in Nouv Presse Med on March 08, 1975
Clinical significance of in vitro synergism between antibiotics in gram-negative infections. Antimicrob Agents Chemother (1972) 3.21
Isolation of AIDS virus from cell-free breast milk of three healthy virus carriers. Lancet (1985) 2.77
Inhibitors of the RNA and DNA dependent polymerase activities of RNA tumour viruses. Nat New Biol (1971) 1.80
Repression of Escherichia coli carbamoylphosphate synthase: relationships with enzyme synthesis in the arginine and pyrimidine pathways. J Bacteriol (1976) 1.76
Rapid detection of IgG and IgM antibodies for cytomegalovirus by the enzyme linked immunosorbent assay (ELISA). Arch Virol (1978) 1.51
Contraception, papillomavirus, and cervical cancer. Lancet (1992) 1.39
Pneumonia caused by gram-negative bacilli in hospitalized patients presenting malignant disease. Eur J Cancer (1971) 1.22
Letter: Viral-antibody detection by a more sensitive complement-fixation reaction. Lancet (1974) 1.21
Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods. Cancer (1973) 1.20
Ascending myelitis in association with herpes-simplex virus. N Engl J Med (1972) 1.20
Effectiveness of betamethasone in management of severe infections. A double-blind study. N Engl J Med (1971) 1.16
The photoinactivation of an RNA animal virus, vesicular stomatitis virus, with the aid of newly synthesized psoralen derivatives. Nucleic Acids Res (1977) 1.13
Comparison of the humoral and cellular immune response after immunization with live, UV inactivated herpes simplex virus and a subunit vaccine and efficacy of these immunizations. Arch Virol (1976) 1.12
Viral antibodies in the CSF after acute CNS infections. Arch Neurol (1975) 1.08
Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis. Br Med J (Clin Res Ed) (1986) 1.07
[C2 cases of torsion spasm accompanied by chorioathetosis with numerous Lafora bodies in the external part of the globus pallidus]. Acta Neuropathol (1967) 1.06
Complement-fixation antibodies to adenovirus-associated viruses, cytomegaloviruses and herpes simplex viruses in patients with tumors and in control individuals. Am J Epidemiol (1971) 1.06
HIV-1 infectivity and host range modification by cathepsin D present in human vaginal secretions. AIDS (1999) 1.00
Use of carbenicillin and polymyxin B for therapy of gram-negative bacilli infections. Chemotherapy (1971) 1.00
Diagnosis and treatment of herpes encephalitis. A multidisciplinary approach. J Neurol Sci (1971) 0.99
Bacteriological and clinical activity of the ampicillin-gentamicin and cephalothin-gentamicin combinations. Am J Med Sci (1971) 0.96
The use of complement fixation tests to detect Australia antigen-antibody complexes and antibodies to a Tween antigen. Vox Sang (1973) 0.95
Evaluation of gentamicin with carbenicillin in infections due to gram-negative bacilli. Curr Ther Res Clin Exp (1971) 0.94
Antiviral activity of rifamycins and N-aminopiperazines. J Antibiot (Tokyo) (1971) 0.94
e antigen and antibody, DNA polymerase, and inhibitors of DNA polymerase in acute and chronic hepatitis. J Infect Dis (1977) 0.94
Demonstration of human papillomavirus type 2 in a verrucous carcinoma of the foot. Dermatology (1993) 0.94
Increasing antibody titers to herpes simplex virus type 2 during follow-up of women with cervical dysplasia. Am J Epidemiol (1973) 0.93
Significance of persisting IgM anti-HBc antibodies in hepatitis B virus infection. J Med Virol (1981) 0.92
Coupling of homotropic and heterotropic interactions in Escherichia coli aspartate transcarbamylase. J Mol Biol (1982) 0.92
The stimulation of Escherichia coli aspartate transcarbamylase activity by adenosine triphosphate. Relation with the other regulatory conformational changes; a model. J Mol Biol (1978) 0.91
Monoclonal antibodies against baboon endogenous virus and against host cell antigens. J Virol (1982) 0.90
Endotracheal gentamicin for the prevention of bronchial infections in patients with tracheotomy. Int J Clin Pharmacol (1973) 0.90
Lethal oxidative damage to human immunodeficiency virus by human recombinant myeloperoxidase. FEBS Lett (1992) 0.89
Inhibition of HIV infectivity by lactoperoxidase-produced hypothiocyanite. J Biol Buccale (1990) 0.86
Immune response to a DNA free herpes simplex vaccine in man. Arch Virol (1982) 0.85
Antibody and cell-mediated immunity to herpes simplex virus in psychotic depression. J Clin Psychiatry (1978) 0.85
Early diagnosis of Hepatitis B by Dane particle associated DNA polymerase assay. J Gen Virol (1977) 0.85
Bacteriologic and clinical evaluation of minocycline, a new tetracycline. Curr Ther Res Clin Exp (1971) 0.84
Effects of the combination of gentamicin and carbenicillin on the bactericidal activity of serum. J Infect Dis (1972) 0.84
Cell receptors for baboon endogenous virus recognized by monoclonal antibodies. J Virol (1983) 0.84
Inhibition of vaccinia virus growth by 1-methyl-4-aminopiperazine. Nature (1970) 0.84
Herpesvirus type 2 infection and carcinoma of the cerivix. Lancet (1970) 0.84
Herpetic meningitis (type 1) in a case of acute leukemia. Arch Neurol (1973) 0.83
Experimental immunosuppression induced by herpes simplex virus. Arch Virol (1975) 0.82
Detection and identification of human papilloma viral DNA, types 16, 18, and 33, by a combination of polymerase chain reaction and a colorimetric solid phase capture hybridisation assay. J Virol Methods (1998) 0.82
Cell mediated immunity in experimental rubella infections. Arch Virol (1975) 0.82
Bovine leukemia virus-related antigens in lymphocyte cultures infected with AIDS-associated viruses. Science (1985) 0.82
Impaired humoral and cell-mediated immune responses in dialyzed patients after influenza vaccination. Nephron (1983) 0.82
Cell-mediated immune response to simian oncornavirus antigens in pregnant women. J Natl Cancer Inst (1978) 0.81
Use of immune lymphocytes to detect expression of herpetic genome. Nature (1974) 0.81
Clinical efficacy of a herpes simplex subunit vaccine. J Med Virol (1985) 0.81
Neutralization of Mason-Pfizer virus by sera from patients treated for renal disease. J Gen Virol (1978) 0.81
Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. Urology (1994) 0.81
Expression of retrovirus-related antigen in pregnancy. I. Antigens cross-reacting with simian retroviruses in human foetal tissues and cord blood lymphocytes. J Reprod Immunol (1981) 0.81
Interactions of Cibacron Blue F3GA and nucleotides with Escherichia coli aspartate carbamoyltransferase and its subunits. Biochemistry (1982) 0.80
Characterization of a human acute phase protein found in association with rubella virus infection. J Exp Med (1974) 0.80
Factors which influence inactivation of vesicular stomatitis virus by fresh human serum. Virology (1978) 0.80
Attempts at experimental transmission and electron microscopic observations in subacute sclerosing panencephalitis. Neurology (1968) 0.80
Efficacy and immune response to rubella subunits vaccines. Arch Virol (1976) 0.80
Efficacy of a nucleic acid free herpetic subunit vaccine. Arch Virol (1980) 0.79
[Neurologic diseases and measles. Virological and immunologic considerations]. Acta Paediatr Belg (1970) 0.79
[Treatment of lithiasis of the common bile duct by endoscopic sphincterotomy and laparoscopic cholecystectomy]. Ann Chir (1994) 0.79
Comparison of different tests to measure immune responses to primate retroviruses. J Immunol Methods (1979) 0.79
Human papillomavirus type 16 associated with multifocal transitional cell carcinomas of the bladder in two transplanted patients. Transpl Int (1994) 0.79
Measles antibodies in patients with various types of measles infection. Arch Gesamte Virusforsch (1969) 0.79
Comparison of the immunogenicity of hamster cells transformed by adenovirus and Herpes simplex virus. Cancer Res (1975) 0.79
Study of the expression of a glycoprotein of retroviral origin in the plasma of patients with hematologic disorders and in the plasma of normal individuals. Blood (1984) 0.79
[Prolonged fever induced by fluindione]. Rev Med Interne (1995) 0.79
Glycosylation inhibitors block the expression of LAV/HTLV-III (HIV) glycoproteins. Biochem Biophys Res Commun (1986) 0.78
Prognostic significance of hepatitis B antigenemia in kidney transplantation. Nephron (1976) 0.78
Human recombinant myeloperoxidase antiviral activity on cytomegalovirus. J Med Virol (2002) 0.78
Congenital varicella-zoster infection related to maternal disease in early pregnancy. Scand J Infect Dis (1973) 0.78
Incidence of antibodies to adenovirus-associated viruses in patients with tumours or other diseases. Arch Gesamte Virusforsch (1970) 0.77
Spontaneous gastropericardial fistula. Ann Emerg Med (1995) 0.77
Cytomegalovirus infection and graft survival in renal graft recipients. Arch Virol (1978) 0.77
Diagnosis of hepatitis B by Dane particle associated DNA polymerase assay. J Med Virol (1978) 0.77
Multiple sclerosis: oligoclonal IgG, kappa-lambda light chain distribution and measles antibodies in brain extracts. Brain Res (1978) 0.77
Different fates of hepatitis B virus markers during plasma fractionation: a clue to the infectivity of blood derivatives. Vox Sang (1978) 0.77
Specific non-immunoglobulin G antibodies and cell-mediated response to herpes simplex virus antigens in women with cervical carcinoma. Cancer Res (1977) 0.77
Large-scale production of rubella precipitinogens and their use in the diagnostic laboratory. J Clin Microbiol (1975) 0.77
Absence of antibodies to HIV-2/HTLV-4 in six central African nations. AIDS Res Hum Retroviruses (1987) 0.76
Herpes simplex virus and carcinoma of the cervix. Eur J Cancer (1976) 0.76
Human syncytiotrophoblast membrane proteins defined using a heterologous antiserum. Clin Exp Immunol (1985) 0.75
Ultrastructural study of the action of aminopiperazines on transformed cell lines and on nervous system tissue culture. Exp Cell Res (1973) 0.75
Viruses grown in the presence of base analogs: specific alteration of susceptibility to inactivation by radiations, mutagens, and protodyes. Virology (1966) 0.75
The action of sparsomycin and gougerotin on virus growth. J Gen Virol (1968) 0.75
[Serological basis for the determination of congenital rubella during pregnancy]. Bull Soc R Belge Gynecol Obstet (1969) 0.75
Measles antibodies, anti-proteinase and plasminogen distribution in serum and plasma from patients affected with multiple sclerosis and patients affected with non-neurological diseases. J Clin Chem Clin Biochem (1984) 0.75
[Early serologic diagnosis of rubella in children]. Brux Med (1969) 0.75
[Anti-rubella vaccination (Cendehill 51 strain). Preliminary results]. Acta Clin Belg (1968) 0.75
[Results of virological examinations performed in Belgium in 1965-1966-1967 (8 months)]. Brux Med (1968) 0.75
[Rubella]. Brux Med (1967) 0.75